Completed
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
NCT06199934
- Conditions
- COVID-19, COVID-19 Vaccines, Coronaviridae Infections, +11 more
- Locations
-
- Pfizer Global Headquarters New York, United States